|
| 37755384 | Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study. | Int J Surg | 2024 |
| 35031959 | Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy. | Clin Rev Allergy Immunol | 2023 |
| 37760416 | Cost-Effectiveness Analysis of Risk Factor-Based Lung Cancer Screening Program by Low-Dose Computer Tomography in Current Smokers in China. | Cancers (Basel) | 2023 |
| 37491740 | Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil. | Clin Transl Med | 2023 |
| 37595587 | CD44<sup>+</sup> lung cancer stem cell-derived pericyte-like cells cause brain metastases through GPR124-enhanced trans-endothelial migration. | Cancer Cell | 2023 |
| 37625894 | Pan-mediastinal neoplasm diagnosis via nationwide federated learning: a multicentre cohort study. | Lancet Digit Health | 2023 |
| 37518773 | Construction and Validation of a Prognostic Model Based on Novel Senescence-Related Genes in Non-Small Cell Lung Cancer Patients with Drug Sensitivity and Tumor Microenvironment. | Adv Biol (Weinh) | 2023 |
| 37745018 | The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non-small cell lung cancer with sensitive EGFR mutations. | EClinicalMedicine | 2023 |
| 37691866 | International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease. | Transl Lung Cancer Res | 2023 |
| 37574511 | Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial. | Signal Transduct Target Ther | 2023 |
| 37574132 | Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial. | J Thorac Oncol | 2023 |
| 37567793 | Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation study. | Lancet Digit Health | 2023 |
| 38090530 | Microbiota modulate lung squamous cell carcinoma lymph node metastasis through microbiota-geneset correlation network. | Transl Lung Cancer Res | 2023 |
| 38089404 | Third-line or above anlotinib in relapsed and refractory small cell lung cancer patients with brain metastases: A post hoc analysis of ALTER1202, a randomized, double-blind phase 2 study. | Cancer Innov | 2023 |
| 37120511 | Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis. | Respir Res | 2023 |
| 37057112 | Development and validation of a deep transfer learning-based multivariable survival model to predict overall survival in lung cancer. | Transl Lung Cancer Res | 2023 |
| 37453674 | CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8<sup>+</sup>Tim3<sup>+</sup> exhausted T cells in non-small cell lung cancer. | Pharmacol Res | 2023 |
| 37316692 | Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study. | J Cancer Res Clin Oncol | 2023 |
| 37385995 | Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial. | Signal Transduct Target Ther | 2023 |
| 37173789 | Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis. | BMC Med | 2023 |
| 37141294 | KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC. | Int J Cancer | 2023 |
| 37072866 | "Major pathologic response" in lymph nodes: a modified nodal classification for non-small cell lung cancer patients treated with neoadjuvant immunochemotherapy. | Exp Hematol Oncol | 2023 |
| 37403021 | Assessing the genetic relationship between gastroesophageal reflux disease and chronic respiratory diseases: a mendelian randomization study. | BMC Pulm Med | 2023 |
| 37101356 | Predilection site and risk factor of second primary cancer: A pan-cancer analysis based on the SEER database. | Chin Med J (Engl) | 2023 |
| 37072348 | Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer. | J Immunother Cancer | 2023 |
| 37065584 | Real-time assessment of COVID-19 epidemic in Guangdong Province, China using mathematical models. | J Thorac Dis | 2023 |
| 37092136 | Clinical characteristics and treatment strategy of nocardiosis in lung transplant recipients: A single-center experience. | IDCases | 2023 |
| 37062036 | Real-world surgical treatment patterns and clinical outcomes in patients with stages IA-IIIA non-small cell lung cancer: a retrospective multicentric observational study involving 11,958 patients. | J Cancer Res Clin Oncol | 2023 |
| 36588094 | Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment. | Clin Transl Med | 2023 |
| 36782253 | Clinical outcomes and survival following lung transplantation for work-related lung disease: a single-center retrospective cohort study. | J Occup Med Toxicol | 2023 |
| 36441397 | Lung transplantation for anti-MDA5-positive dermatomyositis-associated rapid progressive interstitial lung disease: report of two cases and review of the literature. | Clin Rheumatol | 2023 |
| 36809502 | Risk mapping of lung cancer: a comprehensive appraisal of published meta-analyses incorporating Mendelian randomization studies. | J Cancer Res Clin Oncol | 2023 |
| 36436242 | Cell pellet from fixative medium of transbronchial lung biopsy sample improves lung cancer ancillary test. | Lung Cancer | 2023 |
| 36910098 | Global trends in the burden of esophageal cancer, 1990-2019: results from the Global Burden of Disease Study 2019. | J Thorac Dis | 2023 |
| 36736076 | Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review. | Lung Cancer | 2023 |
| 36703125 | Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients. | BMC Pulm Med | 2023 |
| 36794137 | The association of postoperative radiotherapy with survival in resected N2 non-small cell lung cancer. | J Thorac Dis | 2023 |
| 36793984 | Non-intubated uniportal robotic-assisted thoracic surgery: the future of thoracic surgery? | Ann Cardiothorac Surg | 2023 |
| 36860875 | Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma. | Front Immunol | 2023 |
| 36129602 | Impact of obstructive sleep apnea on cancer risk: a systematic review and meta-analysis. | Sleep Breath | 2023 |
| 36052772 | Results from the IMpower132 China cohort: Atezolizumab plus platinum-based chemotherapy in advanced non-small cell lung cancer. | Cancer Med | 2023 |
| 34062123 | Subxiphoid Versus Unilateral Video-assisted Thoracoscopic Surgery Thymectomy for Thymomas: A Propensity Score Matching Analysis. | Ann Thorac Surg | 2022 |
| 35844026 | Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup analysis of a randomized phase 2 study (ALTER1202). | Front Med | 2022 |
| 35348863 | Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translation. | Eur Radiol | 2022 |
| 35543090 | Dynamic monitoring serum tumor markers to predict molecular features of EGFR-mutated lung cancer during targeted therapy. | Cancer Med | 2022 |
| 35606717 | Construction and validation of a two-gene signature based on SUMOylation regulatory genes in non-small cell lung cancer patients. | BMC Cancer | 2022 |
| 35832456 | The procedure and effectiveness of release maneuvers in tracheobronchial resection and reconstruction. | Transl Lung Cancer Res | 2022 |
| 35832451 | Intraoperative methods for wrapping anastomoses after airway reconstruction: a case series. | Transl Lung Cancer Res | 2022 |
| 35832447 | Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring <i>EGFR</i> or <i>ALK</i> genetic aberration. | Transl Lung Cancer Res | 2022 |
| 35535966 | Advances in lung cancer screening and early detection. | Cancer Biol Med | 2022 |